Modification of triaxial deformation and change of spectrum in $^{25}_{\ \Lambda}MgcausedbyMg caused by \Lambda$ hyperon

The positive-parity states of $^{25}_{\ \Lambda}$Mg with a $\Lambda$ hyperon in $s$ orbit were studied with the antisymmetrized molecular dynamics for hypernuclei. We discuss two bands of $^{25}_{\ \Lambda}$Mg corresponding to the $K^\pi=0^+$ and $2^+$ bands of $^{24}$Mg. It is found that the energy of the $K^\pi = 2^+ \otimes \Lambda_s$ band is shifted up by about 200 keV compared to $^{24}$Mg. This is because the $\Lambda$ hyperon in $s$ orbit reduces the quadrupole deformation of the $K^\pi = 0^+ \otimes \Lambda_s$ band, while it does not change the deformation of the $K^\pi = 2^+ \otimes \Lambda_s$ band significantly.Comment: 19 pages, 3 figure

A 24-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety and Tolerability of the Rivastigmine Patch in Japanese Patients with Alzheimer's Disease

Background: As of 2010, the rivastigmine patch was licensed for the treatment of Alzheimer’s disease (AD) in 64 countries. Methods: This 24-week, multicenter, randomized, double-blind, placebo-controlled study evaluated the efficacy, safety and tolerability of the 5-cm2 (9-mg loading dose; 4.6 mg/24 h delivery rate) and 10-cm2 (18-mg loading dose; 9.5 mg/24 h delivery rate) rivastigmine patch in Japanese patients with AD. Results: In the primary analysis population (intent-to-treat last observation carried forward) at week 24, delayed deterioration was seen with the 10-cm2 patch versus placebo on the Japanese version of the Alzheimer’s Disease Assessment Scale-cognitive subscale (ADAS-J cog; p = 0.005) and the Japanese version of the Clinician’s Interview-Based Impression of Change plus Caregiver Input (CIBIC plus-J; p = 0.067). Participants receiving the rivastigmine patch showed numerically less decline versus placebo at week 24 on the CIBIC plus-J, although this did not reach statistical significance. Statistical significance for the CIBIC plus-J was met following adjustment for body weight and baseline Mini-Mental State Examination score as dynamic allocation factors (p = 0.042) and on the Disability Assessment for Dementia (DAD; p = 0.024) and Mental Function Impairment (MENFIS; p = 0.016) subscales. Serious adverse events were rare and were consistent with the known safety profile of the rivastigmine patch. Conclusion: The rivastigmine patch has a favorable efficacy and tolerability profile in Japanese patients with AD

Effect of anti-inflammatory supplementation with whey peptide and exercise therapy in patients with COPD

SummaryBackgroundOne of the major pathophysiologies in advanced chronic obstructive pulmonary disease (COPD) has been attributed to systemic inflammation. Meta-analysis of the 2005 Cochrane Database concluded the effect of nutritional supplementation alone on stable COPD was insufficient to promote body weight gain or exercise capacity. The aim of this study was to investigate the effectiveness of nutritional supplementation therapy using a nutritional supplement containing whey peptide with low-intensity exercise therapy in stable elderly patients with COPD.MethodIn stable elderly COPD patients with %IBW and %FEV1 of less than 110 and 80%, respectively, anti-inflammatory nutritional supplementation therapy was added to low-intensity exercise therapy. Thirty-six COPD patients were divided into those with and those without the ingestion of an anti-inflammatory nutritional supplement containing whey peptide, which exhibited an anti-inflammatory effect. These two groups were designated as the nutritional support and the control groups, respectively. The body composition, skeletal muscle strength, exercise tolerance, health-related QOL (HRQOL), and inflammatory cytokines were evaluated before and three months after nutritional support combined with exercise therapy in both the nutritional support group and the control group.ResultsIn the nutritional support group, the body weight, %IBW, FM, energy intake, %AC, Alb, PImax, PEmax, 6MWD, WBI, emotional function, and CRQ total were significantly increased, and the levels of hsCRP, IL-6, IL-8, and TNF-α were reduced significantly, while no significant change was noted in any item of physiological evaluation or any biomarker in the control group.ConclusionConcomitant use of a anti-inflammatory nutritional supplement containing whey peptide, which exhibits an anti-inflammatory effect, with exercise therapy in stable elderly COPD patients with %IBW<110% and %FEV1<80% may not only increase body weight but may also inhibit systemic inflammation and thus improve exercise tolerance and HRQOL

A New Milky Way Satellite Discovered In The Subaru/Hyper Suprime-Cam Survey

We report the discovery of a new ultra-faint dwarf satellite companion of the Milky Way based on the early survey data from the Hyper Suprime-Cam Subaru Strategic Program. This new satellite, Virgo I, which is located in the constellation of Virgo, has been identified as a statistically significant (5.5 sigma) spatial overdensity of star-like objects with a well-defined main sequence and red giant branch in their color-magnitude diagram. The significance of this overdensity increases to 10.8 sigma when the relevant isochrone filter is adopted for the search. Based on the distribution of the stars around the likely main sequence turn-off at r ~ 24 mag, the distance to Virgo I is estimated as 87 kpc, and its most likely absolute magnitude calculated from a Monte Carlo analysis is M_V = -0.8 +/- 0.9 mag. This stellar system has an extended spatial distribution with a half-light radius of 38 +12/-11 pc, which clearly distinguishes it from a globular cluster with comparable luminosity. Thus, Virgo I is one of the faintest dwarf satellites known and is located beyond the reach of the Sloan Digital Sky Survey. This demonstrates the power of this survey program to identify very faint dwarf satellites. This discovery of VirgoI is based only on about 100 square degrees of data, thus a large number of faint dwarf satellites are likely to exist in the outer halo of the Milky Way.Comment: typos are corrected, 6 pages, 4 figures, accepted for publication in Ap

カラダ トーク アルイワ カラダ ヒョウゲン ワークショップ ノ エイゾウ キロクカ ニツイテ

ファイル名:karadatalk_dance_with_water_on_Concrete.wmv/m4v は、本論で参照される「コンクリートの水溜まり」映像ファイル名:karadatalk_dance_incense.wmv/m4v は、本論で参照される「お香踊り」映

Tree of motility – A proposed history of motility systems in the tree of life

Motility often plays a decisive role in the survival of species. Five systems of motility have been studied in depth: those propelled by bacterial flagella, eukaryotic actin polymerization and the eukaryotic motor proteins myosin, kinesin and dynein. However, many organisms exhibit surprisingly diverse motilities, and advances in genomics, molecular biology and imaging have showed that those motilities have inherently independent mechanisms. This makes defining the breadth of motility nontrivial, because novel motilities may be driven by unknown mechanisms. Here, we classify the known motilities based on the unique classes of movement-producing protein architectures. Based on this criterion, the current total of independent motility systems stands at 18 types. In this perspective, we discuss these modes of motility relative to the latest phylogenetic Tree of Life and propose a history of motility. During the ~4 billion years since the emergence of life, motility arose in Bacteria with flagella and pili, and in Archaea with archaella. Newer modes of motility became possible in Eukarya with changes to the cell envelope. Presence or absence of a peptidoglycan layer, the acquisition of robust membrane dynamics, the enlargement of cells and environmental opportunities likely provided the context for the (co)evolution of novel types of motility

Computational Prediction of O-linked Glycosylation Sites That Preferentially Map on Intrinsically Disordered Regions of Extracellular Proteins

O-glycosylation of mammalian proteins is one of the important posttranslational modifications. We applied a support vector machine (SVM) to predict whether Ser or Thr is glycosylated, in order to elucidate the O-glycosylation mechanism. O-glycosylated sites were often found clustered along the sequence, whereas other sites were located sporadically. Therefore, we developed two types of SVMs for predicting clustered and isolated sites separately. We found that the amino acid composition was effective for predicting the clustered type, whereas the site-specific algorithm was effective for the isolated type. The highest prediction accuracy for the clustered type was 74%, while that for the isolated type was 79%. The existence frequency of amino acids around the O-glycosylation sites was different in the two types: namely, Pro, Val and Ala had high existence probabilities at each specific position relative to a glycosylation site, especially for the isolated type. Independent component analyses for the amino acid sequences around O-glycosylation sites showed the position-specific existences of the identified amino acids as independent components. The O-glycosylation sites were preferentially located within intrinsically disordered regions of extracellular proteins: particularly, more than 90% of the clustered O-GalNAc glycosylation sites were observed in intrinsically disordered regions. This feature could be the key for understanding the non-conservation property of O-glycosylation, and its role in functional diversity and structural stability